MAZE
Maze Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.12 / 10
Underperform
Technical analysis rates 2.12/10, signaling a weak structure. Dominant bearish indicators include Long Upper Shadow, Long Lower Shadow, and MACD Golden Cross, with no bullish signals detected. Historical win rates for these patterns are modest (e.g., 40.8% for Long Upper Shadow), reinforcing caution. Investors should be mindful of potential downside pressure until a clearer trend emerges.
Analysis Checks(0/3)
Long Upper Shadow
Score1.46/10
Win Rate40.79%
Hist. Signals76
Avg Return-0.31%
Score1.46/10
Win Rate40.79%
Hist. Signals76
Avg Return-0.31%
MACD Golden Cross
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-3.63%
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-3.63%
Long Lower Shadow
Score3.89/10
Win Rate52.63%
Hist. Signals95
Avg Return1.00%
Score3.89/10
Win Rate52.63%
Hist. Signals95
Avg Return1.00%
Long Upper Shadow
Score1.46/10
Win Rate40.79%
Hist. Signals76
Avg Return-0.31%
Score1.46/10
Win Rate40.79%
Hist. Signals76
Avg Return-0.31%
Long Lower Shadow
Score3.89/10
Win Rate52.63%
Hist. Signals95
Avg Return1.00%
Score3.89/10
Win Rate52.63%
Hist. Signals95
Avg Return1.00%
MACD Golden Cross
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-3.63%
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-3.63%
Technical Analysis of MAZE?
- MAZE presents a Underperform setup with a Technical Score of 2.12/10. Key technical indicators highlight an RSI of 54.42 and a MACD of -0.01, with the trend anchored by the 50-Day SMA at 41.51. Traders should monitor key support at 41.00 and resistance at 48.08.
